Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 7, 2014; 20(37): 13343-13368
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13343
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13343
Gene therapy in pancreatic cancer
Si-Xue Liu, Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China
Zhong-Sheng Xia, Ying-Qiang Zhong, Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China
Author contributions: Liu SX performed the research; Liu SX and Xia ZS analyzed the data; Liu SX and Zhong YQ wrote the review.
Correspondence to: Ying-Qiang Zhong, MD, PhD, Professor, Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Yanjiang West Road 107, Guangdong Province, China. zhongyingqiang@21cn.com
Telephone: +86-20-81332598 Fax: +86-20-81332244
Received: October 28, 2013
Revised: December 29, 2013
Accepted: June 12, 2014
Published online: October 7, 2014
Processing time: 344 Days and 16 Hours
Revised: December 29, 2013
Accepted: June 12, 2014
Published online: October 7, 2014
Processing time: 344 Days and 16 Hours
Core Tip
Core tip: This paper tries to present a full picture of gene therapy in pancreatic cancer, providing an unambiguous classification and comprehensive analysis, especially in therapeutic targets and clinical trials worldwide. From our work, you may find the hotspots in related research and the reason why they get there.